On Air Now

Upcoming Shows

Program Schedule »

Tune in to Listen

1590 AM Coldwater, Michigan 95.5 FM Coldwater, Michigan

Weather

Current Conditions(Coldwater,MI 49036)

More Weather »
70° Feels Like: 70°
Wind: W 6 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

AM Thunderstorms 79°

Tonight

Clear 59°

Tomorrow

Sunny 82°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

GSK's Tafinlar named as FDA breakthrough therapy for lung cancer

The logo of GlaxoSmithKline (GSK) is seen on its office building in Shanghai July 12, 2013. REUTERS/Aly Song
The logo of GlaxoSmithKline (GSK) is seen on its office building in Shanghai July 12, 2013. REUTERS/Aly Song

LONDON (Reuters) - British pharmaceutical company GlaxoSmithKline said its Tafinlar cancer treatment had been given FDA breakthrough therapy designation for lung cancer, meaning the drug will be fast-tracked within the U.S. regulatory system.

GSK said that Tafinlar, also known as dabrafenib, was designated an FDA breakthrough therapy on Monday following interim results from an ongoing Phase II study.

Tafinlar is already approved for melanoma, the deadliest form of skin cancer.

(Reporting by Sarah Young, Editing by Paul Sandle)

Comments